Serum Leptin and Nitric Oxide in Chronic Obstructive Pulmonary Disease

Document Type : Original Article

Authors

1 Department of Biochemistry, Sohag Faculty of Medicine, Sohag University

2 Department of Chest Diseases, Sohag Faculty of Medicine, Sohag University

Abstract

Unexplained weight loss is common in patients with chronic obstructive
pulmonary disease (COPD). Leptin not only is a critical regulator of body weight and
appetite, but also serves as an immune-modulator. Nitric oxide (NO) is a potent
relaxant of bronchial and pulmonary artery and leptin has a regulatory role in its
synthesis. In the present study, the association of serum leptin levels with nitric oxide
metabolites (NO) in COPD was investigated. Methods: Serum leptin and NO levels
were measured in COPD patients [males (n=18) and females (n=15)] above forty
years old compared with control group (n=30) in the same age matched group.
Serum leptin levels were measured by enzyme linked immune sorbant assay (ELISA)
technique. NO level was measured by spectrophotometric method. Results: Serum
mean leptin level was significantly lower in COPD male group (9.7 ± 4.1 pg/ml) and
female group (11.1 ± 3.7pg/ml) than corresponding control group (male: 12.7 ±1.4
pg/ml and female: 15.1 ± 1.5pg/ml) ( p <0.01 in both). Also, serum nitric oxide
(nitrite and nitrate) in COPD male (18.4 ± 3.7μmol/L) and female group (15.9 ± 5.6
μmol/L) which was lower than corresponding control group (male: 21.2 ±1.9μmol/L
and female: 24.2 ± 2.5μmol/L) (p <0.01 in both). Conclusions: low serum leptin
associated with COPD is related with low BMI. Associated low nitric oxide serum
level may be related to the pathogenesis of COPD.
 

Files

Share

How to cite

Statistics